Sialadenite

Fattahi TT, Lyu PE, Van Sickels JE. Management of acute suppurative parotitis. J Oral Maxillofac Surg. 2002;60:446-448. Resumo

Kraaij S, Karagozoglu KH, Forouzanfar T, et al. Salivary stones: symptoms, aetiology, biochemical composition and treatment. Br Dent J. 2014 Dec 5;217(11):E23.Texto completo  Resumo

1. Seifert G. Aetiological and histological classification of sialadenitis. Pathologica. 1997;89:7-17. Resumo

2. Abdel Razek AAK, Mukherji S. Imaging of sialadenitis. Neuroradiol J. 2017 Jun;30(3):205-15.Texto completo  Resumo

3. Baer AN, Walitt B. Sjögren syndrome and other causes of sicca in older adults. Clin Geriatr Med. 2017 Feb;33(1):87-103.Texto completo  Resumo

4. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004 Jun 28;164(12):1275-84.Texto completo  Resumo

5. Dafni UG, Tzioufas AG, Staikos P, et al. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis. 1997 Sep;56(9):521-5.Texto completo  Resumo

6. Puxeddu I, Capecchi R, Carta F, et al. Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review. J Immunol Res. 2018;2018:6936727.Texto completo  Resumo

7. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010 Feb;34(2):202-10. Resumo

8. Suresh L, Aguirre A. Subacute necrotizing sialadenitis: a clinicopathological study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Sep;104(3):385-90. Resumo

9. Laskawi R, Schaffranietz F, Arglebe C, et al. Inflammatory diseases of the salivary glands in infants and adolescents. Int J Pediatr Otothinolaryngol. 2006;70:129-136. Resumo

10. Singh SA, Singhal N. Suppurative submandibular sialadenitis in a preterm infant. Int J Pediatr Otothinolaryngol. 2004;68:593-595. Resumo

11. McAdams RM, Mair EA, Rajnik M. Neonatal suppurative submandibular sialadenitis: case report and literature review. Int J Pediatr Otothinolaryngol. 2005;69:993-997. Resumo

12. Ismail EA, Seoudi TM, Al-Amir M, et al. Neonatal suppurative parotitis over the last 4 decades: report of three new cases and review. Pediatr Int. 2013 Feb;55(1):60-4. Resumo

13. Seifert G. Aetiological and histological classification of sialadenitis. Pathologica. 1997;89:7-17. Resumo

14. Fox PC, Ship JA. Salivary gland diseases. In: Greenberg MS, Glick M, Ship JA, ed. Burkket's oral medicine. 11th ed. Hamilton, Ontario: BC Decker. 2008:208-215.

15. Fox RI. Sjogren's syndrome. Lancet. 2005;366:321-331. Resumo

16. Kabasakal Y, Kitapciglu G, Turk T, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006;35:379-383. Resumo

17. Manthorpe R, Manthorpe T. Primary Sjogren's syndrome: epidemiology and prognosis. Akt Rheumatol. 2005;30:27-31.

18. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15-25.Texto completo  Resumo

19. Porola P, Laine M, Virkki L, et al. The influence of sex steroids on Sjogren's syndrome. Ann NY Acad Sci. 2007;1108:426-432. Resumo

20. Goldberg MH, Bevilacqua RG. Infections of salivary glands. Oral and Maxillofac Surg Clin N Am. 1995;7:423-430.

21. Fattahi TT, Lyu PE, Van Sickels JE. Management of acute suppurative parotitis. J Oral Maxillofac Surg. 2002;60:446-448. Resumo

22. Brook I. Acute bacterial suppurative parotitis: microbiology and management. J Craniofac Surg. 2003;14:37-40. Resumo

23. Ellies M, Laskawi R. Diseases of the salivary glands in infants and adolescents. Head Face Med. 2010 Feb 15;6:1.Texto completo  Resumo

24. Krippaehne WW, Hunt TK, Dunphy JE. Acute suppurative parotitis: a study of 161 cases. Ann Surg. 1962;156:251-257.Texto completo  Resumo

25. Carlson ER. Diagnosis and management of salivary gland infections. Oral Maxillofac Surg Clin North Am. 2009 Aug;21(3):293-312. Resumo

26. Salivary gland pathology. In: Neville BW, Damm DD, Allen CM, et al, eds. Oral and maxillofacial pathology. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2008:459.

27. Lombardi T, Samson J, Küffer R. Subacute necrotizing sialadenitis: a form of necrotizing sialometaplasia? Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):972-5.Texto completo  Resumo

28. Gallo A, Martellucci S, Fusconi M, et al. Sialendoscopic management of autoimmune sialadenitis: a review of literature. Acta Otorhinolaryngol Ital. 2017 Apr;37(2):148-54.Texto completo  Resumo

29. Tiemann M, Teymoortash A, Schrader C, et al. Chronic sclerosing sialadenitis of the submandibular gland is mainly due to a T lymphocyte immune reaction. Mod Pathol. 2002 Aug;15(8):845-52.Texto completo  Resumo

30. Papadaki ME, McCain JP, Kim K, et al. Interventional sialoendoscopy: early clinical results. J Oral Maxillofac Surg. 2008;66;954-962. Resumo

31. Kraaij S, Karagozoglu KH, Forouzanfar T, et al. Salivary stones: symptoms, aetiology, biochemical composition and treatment. Br Dent J. 2014 Dec 5;217(11):E23.Texto completo  Resumo

32. Blanco M, Mesko T, Cura M, et al. Chronic sclerosing sialadenitis (Kuttner's tumor): unusual presentation with bilateral involvement of major and minor salivary glands. Am Diagn Pathol. 2003;7:25-30. Resumo

33. Williams HK, Connor R, Edmondson H. Chronic sclerosing sialadenitis of submandibular and parotid glands. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:720-723. Resumo

34. Fowler CB, Brannon RB. Subacute necrotizing sialadenitis: report of 7 cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 May;89(5):600-9. Resumo

35. Spijkervet FK, Haacke E, Kroese FG, et al. Parotid Gland Biopsy, the Alternative Way to Diagnose Sjögren Syndrome. Rheum Dis Clin North Am. 2016 Aug;42(3):485-99. Resumo

36. McGuirt WF Jr, Whang C, Moreland W. The role of parotid biopsy in the diagnosis of pediatric Sjögren syndrome. Arch Otolaryngol Head Neck Surg. 2002 Nov;128(11):1279-81.Texto completo  Resumo

37. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92.Texto completo  Resumo

38. Vogl TJ, Al-Nawas B, Beutner D, et al. Updated S2K AWMF guideline for the diagnosis and follow-up of obstructive sialadenitis--relevance for radiologic imaging. Rofo. 2014;186:843-846.Texto completo  Resumo

39. Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, et al. Salivary Secretory Disorders, Inducing Drugs, and Clinical Management. Int J Med Sci. 2015;12(10):811-24.Texto completo  Resumo

40. Jiao A, Farsad K, McVinnie DW, et al. Characterization of iodide-induced sialadenitis: meta-analysis of the published case reports in the medical literature. Acad Radiol. 2020 Mar;27(3):428-35.Texto completo  Resumo

41. Chandra SR. Sialoendoscopy: review and nuances of technique. J Maxillofac Oral Surg. 2019 Mar;18(1):1-10.Texto completo  Resumo

42. Ko YC, Philipone E, Florin W, et al. Subacute necrotizing sialadenitis: a series of three cases and literature review. Head Neck Pathol. 2016 Dec;10(4):425-8.Texto completo  Resumo

43. Troeltzsch M, Pache C, Probst FA, et al. Antibiotic concentrations in saliva: a systematic review of the literature, with clinical implications for the treatment of sialadenitis. J Oral Maxillofac Surg. 2014;72:67-75.Texto completo  Resumo

44. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. November 2018 [internet publication].Texto completo

45. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. March 2019 [internet publication].Texto completo

46. Food and Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. December 2016 [internet publication].Texto completo

47. Food and Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication].Texto completo

48. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. October 2018 [internet publication].Texto completo

49. Marchal F, Bradley PJ. Treatment of infections and inflammatory conditions. In: Management of infections of the salivary glands. Berlin, Germany: Springer Berlin Heidelberg. 2007:169-176.

50. National Institute for Health and Care Excellence. Therapeutic sialendoscopy - Interventional procedures guidance [IPG218]. May 2007 [internet publication].Texto completo

51. Strychowsky JE, Sommer DD, Gupta MK, et al. Sialendoscopy for the management of obstructive salivary gland disease: A systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2012;138:541-547. Resumo

52. Su YX, Lao XM, Zheng GS, et al. Sialoendoscopic management of submandibular gland obstruction caused by intraglandular foreign body. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e17-e21. Resumo

53. Moody AB, Avery CM, Walsh S, et al. Surgical management of chronic parotid disease. Br J Oral Maxillofac Surg. 2000;38:620-622. Resumo

54. Moody AB, Avery CM, Taylor J, et al. A comparison of 150 consecutive parotidectomies for tumours and inflammatory disease. Int J Oral Maxillofac Surg. 1999;28:211-215. Resumo

55. Amin MA, Bailey BM, Patel SR. Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg. 2001;39:348-352. Resumo

56. Patel RS, Low TH, Gao K, et al. Clinical outcome after surgery for 75 patients with parotid sialadenitis. Laryngoscope. 2007;117:644-647. Resumo